Mengwei Zhang

2.2k citations
120 papers · 1.4k indexed · h-index 21
Topics
Cancer Treatment and Pharmacology (12 papers)Advanced Breast Cancer Therapies (9 papers)HER2/EGFR in Cancer Research (8 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Mengwei Zhang

108 papers receiving 1.4k citations

Peers

Mengwei Zhang
Comparison fields: 5 of 137
  • Molecular Biology 508
  • Plant Science 297
  • Oncology 159
  • Nutrition and Dietetics 150
  • Food Science 127
Replace Shanthy Sundaram with:
Shanthy Sundaram India
Qin Wang China
Xinyu Yang China
Yanyun Zhu China
Mi-Sun Kim South Korea
Margarida M. S. M. Bastos Portugal
Anamika Sharma India
Ru Li China
Gothandam Kodiveri Muthukaliannan India
Zhihua Song China
Mengwei Zhang relative to Shanthy Sundaram India Shanthy Sundaram's profile →
Citations per field
00.5×3.0×
Shanthy Sundaram · 1×
Citations per year

Countries citing papers authored by Mengwei Zhang

Since Specialization
Citations

This map shows the geographic impact of Mengwei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengwei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengwei Zhang more than expected).

Fields of papers citing papers by Mengwei Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengwei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengwei Zhang. The network helps show where Mengwei Zhang may publish in the future.

Co-authorship network of co-authors of Mengwei Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Mengwei Zhang. A scholar is included among the top collaborators of Mengwei Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengwei Zhang. Mengwei Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 8
4 5
5 1
6 10
7 70
8 20
9 17
10 5
11 8
12 28
13 7
14 17
15 2
16 0
17 3
18 5
19 21
20 14

About Mengwei Zhang

Mengwei Zhang is a scholar working on Oncology, Applied Microbiology and Biotechnology and Pulmonary and Respiratory Medicine, having authored 120 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), Advanced Breast Cancer Therapies (9 papers) and HER2/EGFR in Cancer Research (8 papers). The work is most often cited by research in Biochemistry (113 citations), Nutrition and Dietetics (150 citations) and Pollution (99 citations). Mengwei Zhang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Suwen Lu, Jinkai Liu, Qiang Xia, Jianxin Zhao, Shumao Cui, Xin Tang, Qiuxiang Zhang, Xuetao Guo, Bingyong Mao and Jinggui Fang. Their work appears in journals such as Journal of the American Chemical Society, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026